<SANITIZED>

Document Type: 
Collection: 
Document Number (FOIA) /ESDN (CREST): 
06159136
Release Decision: 
RIPPUB
Original Classification: 
U
Document Page Count: 
12
Document Creation Date: 
March 9, 2023
Document Release Date: 
February 27, 2020
Sequence Number: 
Case Number: 
F-2009-01030
Publication Date: 
April 15, 2005
File: 
AttachmentSize
PDF icon SANITIZED[15789380].pdf123.99 KB
Body: 
� ArAr AireApr:;vzdZor Release: 2.00/02/25 C06159,6 r ROUTING TO: NAME AND ADDRESS DATE INITIALS 1 2 3 4 ACTION DIREC'TFEPLY PREPARE REPLY APPROVAL DISPATCH RECOMMENDATION commegr RE FETURN CONCURRENCE INFORMTION SIGNATURE REMARKS: FROM: NAME, ADDRESS, AND PHONE NO. DATE (b)(1) (b)(3) Handle Via (b)(3) CONTROL NO COPY Channels (b)(3) Access to this document will be restricted to those approved for the following specific activities: NATIONAL SECURITY INFORMATION Unauthorized Disclosure Subject to Criminal Sanctions THIS COVER SHEET IS UNCLASSIFIED WHEN BLANK rArAllrAPPor OF AMN 02315 Approved for Release: 2020/02/25 C06159136 j-rK. elakr0 lid; 47RM Approved for Release: 2020/02/25 C06159136 NO. 532 -140P-SEeftErTh (b)(1) (b)(3) blgsPtillefrelpIst- To: Organization: Phone: Fax me. From: Organization: Phone: Fax: FAX COVER SHEET Central Intelligence Agency Washington, DC 20505 15 April 2005 DOJ Command Center For Office of Legal Counsel U.S. Department of Justice � (b)(3) (b)(6) Legal Group DO Counterterrorist Center (b)(3) P.1 Number of pages (including cover sheet): (b)(6)� Comments: ZESR47) Answers to your questions. A 1. More on successes. 2. Intel value of Gul. NOTICE, TO RECIPIENT AMN 02316 This information is property of the United States intended solely for the use glebe entity or person named above and also may be attorney-client privileged or otherwise exentprfrom disclosure under applicable /am If you are not the WU:tided recipient of thi,v facsimile, or die employee or agent responsible for delivering the message w the intended recipient, you ore hereby notified that receipt of this message is no/a waiver or release 41, my applicable privilege or exemption from disclosure, and that review. dissemination, distribution, or copying of this communication is strictly Med. Ifyou have received this material in error. please nonfy this Vice en the (Mot, l telephone number (collect) for instructions regarding its rn Or destruction, Thank you. 4-011-5EFEE-Ti (b)(1) (b)(3)� (b)(3) 4441+ (b)(6) (b)(3) (b)(6) Approved for Release: 2020/02/25 C06159136 mrm.10.G0= 110i4dH1 ' Approved for Release: 2020/02/25 C06159136 � (b)(3) SECRET/ NOFORNMVIR NO.532 P.2 Janat Gul (b)(1) Janet Gul--arrested (b)(3) on June 2004 and transferred to US custody --was a key Tallinn and Islamic Movement of Uzbekistan (Ii U) facilitator. Various reporting Indicates that Gul worked as a facilitator and courier for al-Qa'ida field commander and senior leader 'Abd al-Hadi al-Iraqi; at the same time, he was also aiding the IMU and former Taliban leadership, Since his detention, Gul has provided information that has been contained In some 70 Intelligence reports about Taliban, IMU, and al-Qatida associates and members in Pakistan; however, 20 percent of those reports are statements of non-recognition of individuals. Moreover, during most of Gul's debriefings, he has sought to minimize his knowledge of extremist activities and has provided largely non-incriminating information about his involvement in their networks, � Gul has provided information about his efforts to transfer a small number of Arab fighters to Shkai, Pakistan to join 'Abd al-Hadi al-Iraqi, his attempt to deliver a letter from the IMU leader to the Taliban leadership containing a request for SAM-7 missiles, and other efforts to facilitate the travel of mujahidin or procurement of materiel. He has provided few details, however, on the individuals he employed when facilitating the movement of Arab fighters and equipment. � (b)(1) (b)(3) (b)(1) * (b)(3), (b)(1) (b)(3) (b)(3) (1)(3) AMN 02317 SECRET// (b)(3) ,NOFORNU/MR Approved for Release: 2020/02/25 C06159136 .t..rx.i.eum 10:49RM Approved for Release: 2020/02/25 C06159136 SECRET/ NOFORLs1//MR NO.532 P.3 2 � SECRET (b)(3) 10FORIVIVIR AMN 02318 (b)(1) (b)(3) Approved for Release: 2020/02/25 C06159136 Approved for Release: 2020/02/25 C06159136 (b)(1) (b)(3) (b)(6) (b)(7)(a) (b)(7)(b) (b)(7)(c) Approved for Release: 2020/02/25 C06159136 Approved for Release: 2020/02/25 C06159136 (b)(1) (b)(3) (b)(6) (b)(7)(a) (b)(7)(b) (b)(7)(c) Approved for Release: 2020/02/25 C06159136 Approved for Release: 2020/02/25 C06159136 (b)(1) (b)(3) (b)(6) (b)(7)(a) (b)(7)(b) (b)(7)(c) Approved for Release: 2020/02/25 C06159136 Approved for Release: 2020/02/25 C06159136 (b)(1) (b)(3) (b)(6) (b)(7)(a) (b)(7)(b) (b)(7)(c) Approved for Release: 2020/02/25 C06159136 Approved for Release: 2020/02/25 C06159136 (b)(1) (b)(3) (b)(6) (b)(7)(a) (b)(7)(b) (b)(7)(c) Approved for Release: 2020/02/25 C06159136 Approved for Release: 2020/02/25 C06159136 (b)(1) (b)(3) (b)(6) (b)(7)(a) (b)(7)(b) (b)(7)(c) Approved for Release: 2020/02/25 C06159136 Approved for Release: 2020/02/25 C06159136 (b)(1) (b)(3) (b)(6) (b)(7)(a) (b)(7)(b) (b)(7)(c) Approved for Release: 2020/02/25 C06159136 Approved for Release: 2020/02/25 C06159136 (b)(1) (b)(3) (b)(6) (b)(7)(a) (b)(7)(b) (b)(7)(c) Approved for Release: 2020/02/25 C06159136